Xylem Stock Exhibits Strong Prospects Despite Persisting Headwinds
XYL's growth in smart metering, infrastructure projects and acquisitions fuels momentum, despite rising costs and global headwinds.
Here's Why Xylem (XYL) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Xylem Inc. (XYL) Q2 2025 Earnings Call Transcript
Xylem Inc. (NYSE:XYL ) Q2 2025 Earnings Conference Call July 31, 2025 9:00 AM ET Company Participants Keith Buettner - Corporate Participant Matthew Francis Pine - CEO, President & Director William K. Grogan - Senior VP & CFO Conference Call Participants Andrew Alec Kaplowitz - Citigroup Inc., Research Division Andrew Edouard Buscaglia - BNP Paribas Exane, Research Division Deane Michael Dray - RBC Capital Markets, Research Division Jacob Frederick Levinson - Melius Research LLC Mark Wesley Strouse - JPMorgan Chase & Co, Research Division Michael Patrick Halloran - Robert W.
Xylem Tops Q2 Earnings & Revenue Estimates, Raises '25 Outlook
XYL posts solid Q2 beat with 16% EPS growth and ups full-year guidance on strong demand across all business segments.
Xylem (XYL) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Xylem (XYL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Xylem (XYL) Q2 Earnings and Revenues Beat Estimates
Xylem (XYL) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.09 per share a year ago.
Countdown to Xylem (XYL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Xylem (XYL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Xylem: Robust Long-Term Growth Runway
I rate Xylem a buy, driven by secular water scarcity, aging infrastructure, and PFAS treatment themes that ensure durable, non-discretionary demand. XYL's 80/20 transformation is already delivering tangible margin gains, with further upside from the Evoqua integration and PFAS funding pipeline. Despite near-term softness in some segments and tariff headwinds, XYL's long-term growth is underpinned by resilient end markets and internal self-help levers.
Xylem (XYL) Up 4.2% Since Last Earnings Report: Can It Continue?
Xylem (XYL) reported earnings 30 days ago. What's next for the stock?
Here's Why Investors Should Consider Retaining Xylem Stock Now
XYL gains from strength across end markets, robust backlog level and the acquisition of Evoqua. However, rising operating costs and expenses might dent its margins.
Xylem Inc. (XYL) Q1 2025 Earnings Call Transcript
Xylem Inc. (NYSE:XYL ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Keith Buettner - Vice President, Investor Relations & Financial Planning & Analysis Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Baird Scott Davis - Melius Research Nathan Jones - Stifel Saree Boroditsky - Jefferies Bryan Blair - Oppenheimer Joe Giordano - TD Cowen Operator Good day, and welcome to Xylem's First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Xylem's Q1 Earnings & Revenues Top Estimates, Orders Down Y/Y
XYL's first-quarter 2025 revenues increase 2% year over year, driven by the impressive performances of its Water Infrastructure and Measurement & Control units.
